Jacob A Schwartzman (Jacob Schwartzman)

Years Active: 2019-2021
Publications (10 Years): 2

Oregon Health and Science University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oregon Health and Science University

United States

Research Assistant :: Knight Cancer Institute Prostate Program

Publications

Dae-Hwan Kim, Duanchen Sun, William K Storck, Katherine Welker Leng, Chelsea Jenkins, Daniel J Coleman, David Sampson, Xiangnan Guan, Anbarasu Kumaraswamy, Eva S Rodansky, Joshua A Urrutia, Jacob A Schwartzman, Chao Zhang, Himisha Beltran, Mark P Labrecque, Colm Morrissey, Jared M Lucas, Ilsa M Coleman, Peter S Nelson, Eva Corey, Samuel K Handelman, Jonathan Z Sexton, Rahul Aggarwal, Wassim Abida, Felix Y Feng, Eric J Small, Daniel E Spratt, Armand Bankhead, Arvind Rao, Emily M Gesner, Sarah Attwell, Sanjay Lakhotia, Eric Campeau, Joel A Yates, Zheng Xia, Joshi J Alumkal
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Daniel J Coleman, Lina Gao, Carly J King, Jacob A Schwartzman, Joshua A Urrutia, Archana Sehrawat, Junior Tayou, Ariel Balter, Julja Burchard, Kami E Chiotti, Daniel S Derrick, Duanchen Sun, Zheng Xia, Laura M Heiser, Joshi J Alumkal
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer. Oncogene 38 (28) (2019)

Jacob A Schwartzman.css-eqlu8i{font-size:small;padding-left:4px;} (Jacob Schwartzman)